Next Quarterly Earnings
Wednesday, October 28, 2026
CW 44
Pre-Market
In 62 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkermes
Alkermes is an innovative pharmaceutical company headquartered in Ireland, specializing in the research, development, and commercialization of novel medicines. The company focuses on providing groundbreaking therapies for patients with complex neurological and psychiatric diseases. Alkermes drives global healthcare forward through scientific excellence to improve quality of life.
Frequently asked questions
When will Alkermes report its next quarterly earnings?
Alkermes is scheduled to report its next quarterly earnings on 10/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Alkermes last report quarterly earnings?
Alkermes last reported quarterly earnings on 7/28/2026 (Q2 2026). Earnings per share (EPS) came in at 0.00 USD.
How does Alkermes stock react to earnings?
Across its last 4 earnings reports, Alkermes stock moved by ±5.6% on average the following day. The largest reaction was -7% on 02/25/2026; 3 of 4 reactions were positive.
How often has Alkermes beaten expectations?
Alkermes has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Alkermes earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±5.6%
Avg. next-day move
-7%
Largest move (02/25/2026)
75%
Share of positive reactions
±9.7%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+19.8%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.